SciVision Biotech Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 120.960 million compared to TWD 102.812 million a year ago. Operating income was TWD 37.388 million compared to TWD 28.086 million a year ago. Net income was TWD 34.004 million compared to TWD 25.685 million a year ago. Basic earnings per share was TWD 0.56 compared to TWD 0.42 a year ago. Diluted earnings per share was TWD 0.54 compared to TWD 0.42 a year ago. For the nine months, sales was TWD 334.954 million compared to TWD 308.062 million a year ago. Operating income was TWD 101.851 million compared to TWD 87.568 million a year ago. Net income was TWD 92.708 million compared to TWD 80.841 million a year ago. Basic earnings per share was TWD 1.52 compared to TWD 1.34 a year ago. Diluted earnings per share was TWD 1.48 compared to TWD 1.3 a year ago.